PTPN1 and fatty liver disease: We have evaluated the insulin signaling pathway, DNL, adipocytes differentiation, augmentation of lipoproteins clearance and fatty acid uptake, lipid droplet formation, antilipolysis activity, and hepatic steatosis of PTP1B inhibition in adipocytes and hepatocytes of HFD-STZ–induced diabetic mice model.